112 related articles for article (PubMed ID: 1319617)
21. Activation of protein C and its distribution between its inhibitors, protein C inhibitor, alpha 1-antitrypsin and alpha 2-macroglobulin, in patients with disseminated intravascular coagulation.
Scully MF; Toh CH; Hoogendoorn H; Manuel RP; Nesheim ME; Solymoss S; Giles AR
Thromb Haemost; 1993 May; 69(5):448-53. PubMed ID: 7686692
[TBL] [Abstract][Full Text] [Related]
22. Heparin stimulation of the inhibition of activated protein C and other enzymes by human protein C inhibitor--influence of the molecular weightof heparin and ionic strength.
Aznar J; España F; Estellés A; Royo M
Thromb Haemost; 1996 Dec; 76(6):983-8. PubMed ID: 8972021
[TBL] [Abstract][Full Text] [Related]
23. Histidine-rich glycoprotein binds to human IgG and C1q and inhibits the formation of insoluble immune complexes.
Gorgani NN; Parish CR; Easterbrook Smith SB; Altin JG
Biochemistry; 1997 Jun; 36(22):6653-62. PubMed ID: 9184145
[TBL] [Abstract][Full Text] [Related]
24. Role of the A+ helix in heparin binding to protein C inhibitor.
Elisen MG; Maseland MH; Church FC; Bouma BN; Meijers JC
Thromb Haemost; 1996 May; 75(5):760-6. PubMed ID: 8725720
[TBL] [Abstract][Full Text] [Related]
25. Protein C inhibitor and other components of the protein C pathway in patients with acute deep vein thrombosis during heparin treatment.
Tabernero D; España F; Vicente V; Estellés A; Gilabert J; Aznar J
Thromb Haemost; 1990 Jun; 63(3):380-2. PubMed ID: 2169656
[TBL] [Abstract][Full Text] [Related]
26. Neutralization of the anticoagulant effects of glycosaminoglycans by serum amyloid P component: comparison with other plasma and platelet proteins.
Williams EC; Huppert BJ; Asakura S
J Lab Clin Med; 1992 Jul; 120(1):159-67. PubMed ID: 1377216
[TBL] [Abstract][Full Text] [Related]
27. Hereditary increase of plasma histidine-rich glycoprotein associated with abnormal heparin binding (HRG Eindhoven).
Hoffmann JJ; Hennis BC; Kluft C; Vijgen M
Thromb Haemost; 1993 Dec; 70(6):894-9. PubMed ID: 8165607
[TBL] [Abstract][Full Text] [Related]
28. Zinc as a cofactor for heparin neutralization by histidine-rich glycoprotein.
Kluszynski BA; Kim C; Faulk WP
J Biol Chem; 1997 May; 272(21):13541-7. PubMed ID: 9153200
[TBL] [Abstract][Full Text] [Related]
29. Functional consequences of mutations in amino acid residues that stabilize calcium binding to the first epidermal growth factor homology domain of human protein C.
Geng JP; Cheng CH; Castellino FJ
Thromb Haemost; 1996 Nov; 76(5):720-8. PubMed ID: 8950780
[TBL] [Abstract][Full Text] [Related]
30. Induction of inhibitory activity for B cell differentiation in human CD8 T cells with pokeweed mitogen, dimaprit, and cAMP upregulating agents: countersuppressive effect of platelet factor 4.
Crisi GM; Katz IR; Zucker MB; Thorbecke GJ
Cell Immunol; 1996 Sep; 172(2):205-16. PubMed ID: 8964082
[TBL] [Abstract][Full Text] [Related]
31. Full or partial substitution of the reactive center loop of alpha-1-proteinase inhibitor by that of heparin cofactor II: P1 Arg is required for maximal thrombin inhibition.
Filion ML; Bhakta V; Nguyen LH; Liaw PS; Sheffield WP
Biochemistry; 2004 Nov; 43(46):14864-72. PubMed ID: 15544357
[TBL] [Abstract][Full Text] [Related]
32. Beta2-glycoprotein I is necessary to inhibit protein C activity by monoclonal anticardiolipin antibodies.
Ieko M; Ichikawa K; Triplett DA; Matsuura E; Atsumi T; Sawada K; Koike T
Arthritis Rheum; 1999 Jan; 42(1):167-74. PubMed ID: 9920027
[TBL] [Abstract][Full Text] [Related]
33. Thrombin signal transduction mechanisms in human glomerular epithelial cells.
He CJ; Peraldi MN; Adida C; Rebibou JM; Meulders Q; Sraer JD; Rondeau E
J Cell Physiol; 1992 Mar; 150(3):475-83. PubMed ID: 1537879
[TBL] [Abstract][Full Text] [Related]
34. Interrelationship of protamine and platelet factor 4 in the neutralization of heparin.
Shanberge JN; Quattrociocchi-Longe TM; Martens MH
Thromb Res; 1987 Apr; 46(1):89-100. PubMed ID: 3590116
[TBL] [Abstract][Full Text] [Related]
35. Histidine-rich glycoprotein modulation of the anticoagulant activity of heparin. Evidence for a mechanism involving competition with both antithrombin and thrombin for heparin binding.
Peterson CB; Morgan WT; Blackburn MN
J Biol Chem; 1987 Jun; 262(16):7567-74. PubMed ID: 3584128
[TBL] [Abstract][Full Text] [Related]
36. Platelet factor 4 stimulates thrombomodulin protein C-activating cofactor activity. A structure-function analysis.
Slungaard A; Key NS
J Biol Chem; 1994 Oct; 269(41):25549-56. PubMed ID: 7523387
[TBL] [Abstract][Full Text] [Related]
37. Studies on the purification and characteristics of histidine-rich glycoprotein.
Sakuragawa N; Niwa M; Yamagishi R
Semin Thromb Hemost; 1985 Oct; 11(4):384-6. PubMed ID: 4071064
[TBL] [Abstract][Full Text] [Related]
38. Histidine-rich glycoprotein: a possible modulator of coagulation and fibrinolysis.
Wakabayashi S; Koide T
Semin Thromb Hemost; 2011 Jun; 37(4):389-94. PubMed ID: 21805445
[TBL] [Abstract][Full Text] [Related]
39. Histidine-rich glycoprotein binding to T-cell lines and its effect on T-cell substratum adhesion is strongly potentiated by zinc.
Olsen HM; Parish CR; Altin JG
Immunology; 1996 Jun; 88(2):198-206. PubMed ID: 8690451
[TBL] [Abstract][Full Text] [Related]
40. Purification and characterization of plasma protein C inhibitor.
España F; Berrettini M; Griffin JH
Thromb Res; 1989 Aug; 55(3):369-84. PubMed ID: 2551064
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
